FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00145314 |
Recruitment Status :
Completed
First Posted : September 5, 2005
Last Update Posted : January 14, 2011
|
Sponsor:
The Nordic Colorectal Cancer Biomodulation Group
Information provided by:
The Nordic Colorectal Cancer Biomodulation Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | May 2009 |
Actual Study Completion Date : | August 2010 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):